HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Treatment of hyponatremia: new developments and controversies].

Abstract
This article summarizes improvements in diagnosis and therapy in patients with symptomatic hyponatremia. The available treatment options for hyponatremia have been limited, and consisted mainly of isotonic or hypertonic saline, urea, and fluid restriction. Vasopressin receptor antagonists, also known as vaptans or aquaretics are a new class of drugs that now offer an additional treatment option for hyponatremic patients with euvolemic hyponatremia due to SIADH in Europe. In short and long term studies, tolvaptane has been shown to be effective in raising serum sodium levels in a predictable fashion in patients with SIADH with only few side effects, when serum sodium was frequently monitored and dosage of tolvaptans was properly adjusted. Further studies are needed to find out which patients benefit from treatment with respect to morbidity and mortality. Until now, therapy is limited to the treatment of moderate symptomatic hyponatremia in SIADH due to the high cost of therapy.
AuthorsJ Hensen
JournalDeutsche medizinische Wochenschrift (1946) (Dtsch Med Wochenschr) Vol. 136 Issue 17 Pg. 904-9 (Apr 2011) ISSN: 1439-4413 [Electronic] Germany
Vernacular TitleTherapie der Hyponatriämie: neue Erkenntnisse und Kontroversen.
PMID21523644 (Publication Type: Journal Article, Review)
Copyright© Georg Thieme Verlag KG Stuttgart · New York.
Chemical References
  • Antidiuretic Hormone Receptor Antagonists
  • Benzazepines
  • Saline Solution, Hypertonic
  • Sodium Chloride Symporter Inhibitors
  • Tolvaptan
  • Sodium Chloride
  • Urea
  • Sodium
Topics
  • Antidiuretic Hormone Receptor Antagonists
  • Benzazepines (therapeutic use)
  • Blood Volume (drug effects, physiology)
  • Drinking (physiology)
  • Humans
  • Hyponatremia (chemically induced, diagnosis, drug therapy, physiopathology)
  • Inappropriate ADH Syndrome (diagnosis, drug therapy, physiopathology)
  • Saline Solution, Hypertonic
  • Sodium (blood)
  • Sodium Chloride
  • Sodium Chloride Symporter Inhibitors (adverse effects, therapeutic use)
  • Tolvaptan
  • Urea (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: